Pneumocystis jiroveci pneumonia.
Luks
Andrew M
AM
Division of Pulmonary and Critical Care Medicine, University of Washington, Seattle, Washington, USA. aluks@u.washington.edu
Neff
Margaret J
MJ
D017088:AIDS-Related Opportunistic Infections / Q000150:complications* / Q000000981:diagnostic imaging / Q000188:drug therapy; D000890:Anti-Infective Agents / Q000627:therapeutic use; D001999:Bronchoscopy; D018791:CD4 Lymphocyte Count; D004359:Drug Therapy, Combination; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D000860:Hypoxia / Q000209:etiology / Q000628:therapy; D008875:Middle Aged; D010102:Oxygen Inhalation Therapy; D045363:Pneumocystis carinii / Q000302:isolation & purification*; D011020:Pneumonia, Pneumocystis / Q000150:complications* / Q000000981:diagnostic imaging / Q000188:drug therapy; D011241:Prednisone / Q000627:therapeutic use; D013902:Radiography, Thoracic; D014057:Tomography, X-Ray Computed; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use
D000890:Anti-Infective Agents; D005938:Glucocorticoids; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D011241:Prednisone